Prognostic significance of the number of tumor (+) N2 nodes in N2 stage IIIA non-small cell lung cancer after curative resection.

被引：0
|
作者：
Yoo, C.
Yoon, S.
Lee, D.
Suh, C.
Lee, J.
Park, S.
Kim, D.
Kim, Y.
Kim, W.
Kim, S.
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac Surg, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulmonol & Crit Care Med, Seoul, South Korea
[4] Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7023
引用
收藏
页数：1
相关论文
共 50 条
  • [31] MANAGEMENT OF N2 NON-SMALL CELL LUNG CANCER
    Shetty, Preethi S.
    Mankar, Hemant
    Pramesh, C. S.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 152 (05): : 1463 - 1464
  • [32] Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: A prospective study
    Cerfolio, Robert James
    Bryant, Ayesha S.
    Ojha, Buddhiwardhan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 131 (06): : 1229 - 1235
  • [33] Prognostic factors of N2 positive stage IIIA non-small cell lung cancer treated with preoperative concurrent radiochemotherapy and surgery
    Ahn, Y
    Kim, K
    Nam, H
    Oh, D
    Park, Y
    Lim, D
    Han, J
    Park, J
    Kim, J
    Kim, K
    LUNG CANCER, 2005, 49 : S165 - S165
  • [34] Skip mediastinal nodal metastases in the IIIA/N2 non-small cell lung cancer
    Ilic, N
    Petricevic, A
    Tanfara, S
    Kotarac, S
    Arar, D
    Mise, K
    Ilic, NF
    Banovic, J
    LUNG CANCER, 2005, 49 : S281 - S281
  • [35] Prognostic Advantage by postoperative Radiation Therapy in addition to adjuvant Chemotherapy in non-small Cell Lung Cancer in Stage IIIA/N2
    Nieder, Carsten
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (06) : 539 - 540
  • [36] Skip mediastinal nodal metastases in the IIIA/N2 non-small cell lung cancer
    Illic, N.
    Petricevic, A.
    Arar, D.
    Kotarac, S.
    Banovic, J.
    Frieta Ilic, N.
    Tripkovic, A.
    Ercegovic, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 328 - 328
  • [37] Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer
    Jeremic, Branislav
    Casas, Francesc
    Dubinsky, Pavol
    Gomez-Caamano, Antonio
    Cihoric, Nikola
    Videtic, Gregory
    Igrutinovic, Ivan
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [38] The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung Cancer
    Daniel C. Thomas
    Brian N. Arnold
    Joshua E. Rosen
    Michelle C. Salazar
    Frank C. Detterbeck
    Justin D. Blasberg
    Daniel J. Boffa
    Anthony W. Kim
    World Journal of Surgery, 2018, 42 : 161 - 171
  • [39] The significance of N2 node involvement at thoracotomy in non-small cell lung cancer
    Old, SE
    Gilligan, D
    Laroche, CM
    THORAX, 1999, 54 : A19 - A19
  • [40] The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung Cancer
    Thomas, Daniel C.
    Arnold, Brian N.
    Rosen, Joshua E.
    Salazar, Michelle C.
    Detterbeck, Frank C.
    Blasberg, Justin D.
    Boffa, Daniel J.
    Kim, Anthony W.
    WORLD JOURNAL OF SURGERY, 2018, 42 (01) : 161 - 171
12345